» Articles » PMID: 20956980

Molecular Mechanisms of Metastasis in Breast Cancer--clinical Applications

Overview
Specialty Oncology
Date 2010 Oct 20
PMID 20956980
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

The metastatic cascade is a series of biological processes that enable the movement of tumor cells from the primary site to a distant location and the establishment of a new cancer growth. Circulating tumor cells (CTCs) have a crucial role in tumor dissemination. The role of CTCs in treatment failure and disease progression can be explained by their relation to biological processes, including the epithelial-to-mesenchymal transition and 'self seeding', defined as reinfiltration of the primary tumor or established metastasis by more aggressive CTCs. CTCs are a unique and heterogeneous cell population with established prognostic and predictive value in certain clinical situations. The possibility of collecting sequential blood samples for real-time monitoring of systemic-therapy efficacy presents new possibilities to evaluate targeted therapies based on the genomic profiling of CTCs and to improve the clinical management of patients by personalized therapy. Interruption of the metastatic cascade via the targeting of CTCs might be a promising therapeutic strategy.

Citing Articles

Molecular mechanism of bone metastasis in breast cancer.

Sui L, Wang J, Jiang W, Song X, Ye L Front Oncol. 2024; 14:1401113.

PMID: 39605887 PMC: 11599183. DOI: 10.3389/fonc.2024.1401113.


Detection, significance and potential utility of circulating tumor cells in clinical practice in breast cancer (Review).

Rusnakova D, Aziri R, Dubovan P, Jurik M, Mego M, Pindak D Oncol Lett. 2024; 29(1):10.

PMID: 39492933 PMC: 11526295. DOI: 10.3892/ol.2024.14756.


Molecular Mechanism of lncRNAs in Regulation of Breast Cancer Metastasis; a Comprehensive Review.

Ahmadi S, Yazdi F, Khastar S, Kaur I, Ahmed M, Kumar A Cell Biochem Biophys. 2024; 83(1):229-245.

PMID: 39367197 DOI: 10.1007/s12013-024-01535-y.


MCT4 and CD147 colocalize with MMP14 in invadopodia and support matrix degradation and invasion by breast cancer cells.

Meng S, Sorensen E, Ponniah M, Thorlacius-Ussing J, Crouigneau R, Larsen T J Cell Sci. 2024; 137(8).

PMID: 38661040 PMC: 11112124. DOI: 10.1242/jcs.261608.


Molecular interaction of metastasis suppressor genes and tumor microenvironment in breast cancer.

Supuramanian S, Dsa S, Harihar S Explor Target Antitumor Ther. 2023; 4(5):912-932.

PMID: 37970212 PMC: 10645471. DOI: 10.37349/etat.2023.00173.


References
1.
Wong C, Lee A, Shientag L, Yu J, Dong Y, Kao G . Apoptosis: an early event in metastatic inefficiency. Cancer Res. 2001; 61(1):333-8. View

2.
Tsuji T, Ibaragi S, Hu G . Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res. 2009; 69(18):7135-9. PMC: 2760965. DOI: 10.1158/0008-5472.CAN-09-1618. View

3.
Friedl P, Wolf K . Plasticity of cell migration: a multiscale tuning model. J Cell Biol. 2009; 188(1):11-9. PMC: 2812848. DOI: 10.1083/jcb.200909003. View

4.
Peinado H, Marin F, Cubillo E, Stark H, Fusenig N, Nieto M . Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo. J Cell Sci. 2004; 117(Pt 13):2827-39. DOI: 10.1242/jcs.01145. View

5.
Kirwan C, McDowell G, McCollum C, Kumar S, Byrne G . Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer. Br J Cancer. 2008; 99(7):1000-6. PMC: 2567096. DOI: 10.1038/sj.bjc.6604620. View